KMT2A REARRANGEMENT
Clinical trials for KMT2A REARRANGEMENT explained in plain language.
Never miss a new study
Get alerted when new KMT2A REARRANGEMENT trials appear
Sign up with your email to follow new studies for KMT2A REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to keep leukemia in remission after transplant
Disease control Recruiting nowThis study looks at whether menin inhibitors can help prevent leukemia from coming back after a stem cell transplant. About 20 people with certain genetic types of acute leukemia will take these drugs as part of their regular care. Researchers will track how long they stay cancer…
Matched conditions: KMT2A REARRANGEMENT
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New drug hopes to keep leukemia away after transplant
Disease control Recruiting nowThis early-phase study tests an experimental drug called ziftomenib in adults with acute myeloid leukemia (AML) who have had a stem cell transplant. The goal is to find a safe dose and see if the drug can help prevent the cancer from coming back. About 22 participants will take t…
Matched conditions: KMT2A REARRANGEMENT
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC